Latest News

Earlier this week, analysts projected that Ventas would report quarterly earnings of US$0.91 per share and revenues of US$1.58 billion, both higher than a year ago, with the consensus earnings estimate nudged higher over the past month. This upward revision in expectations highlights growing analyst confidence in Ventas’ operational momentum ahead of its upcoming quarterly update. Next, we’ll examine how this improving earnings outlook and analyst sentiment may influence Ventas’ longer-term...

Procore Technologies (PCOR) has drawn fresh attention after appointing artificial intelligence expert Vishal Misra to its Board of Directors, putting governance and product direction in focus for investors watching the construction software group. See our latest analysis for Procore Technologies. Despite the AI focused board appointment, Procore’s recent share price return has been weak. The 90 day share price return is 15.6% and the year to date share price return is 20.9%, while the 3 year...

Kulicke and Soffa Industries recently announced that it would release its second fiscal quarter 2026 results on May 6, 2026, followed by a conference call on May 7, 2026, to discuss its performance and business outlook in semiconductor assembly technology. This update comes as the company faces pressure from postponed customer purchases and weaker margins, yet is now expected to return to sales growth after four consecutive years of declines. We will now examine how expectations for a return...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Event context and recent performance Atlantic Union Bankshares (AUB) has been on investors’ radar after recent share price moves, with the stock showing mixed short term returns and a stronger 1 year total return profile. Over the past week the stock recorded a 3.8% decline, following a 1 day move of around 1.3% lower, while the month performance stands at about 5.9% and the past 3 months show a 3.8% decline. See our latest analysis for Atlantic Union Bankshares. At a share price of $37.40,...

Earlier this month, Neurocrine Biosciences reported new two-year Phase 3 CAHtalyst Adult data showing CRENESSITY enabled sustained reductions in glucocorticoid doses for adults with classic congenital adrenal hyperplasia, with about 70% of patients reaching physiologic dosing and no new safety concerns. The results highlight CRENESSITY’s potential to ease long-term treatment burden by lowering reliance on supraphysiologic steroid doses while maintaining androgen control, a key clinical goal...

American Superconductor recently reported that over the past two years it has delivered very strong annual revenue growth while also reaching positive free cash flow and improving returns on capital, signaling a shift toward financial self-sustainability. This combination of rapid top-line expansion, cash generation, and better capital efficiency suggests that earlier investments in its power resiliency technologies are now translating into tangible operating benefits. Next, we’ll examine...

US Foods Holding (USFD) is back in focus after a series of analyst upgrades tied to its earnings outlook, with attention centering on the role of higher margin private label and value added products. See our latest analysis for US Foods Holding. The recent analyst upgrades come after a strong run, with the share price at $93.20 and a 90 day share price return of 14.68%. The 1 year total shareholder return of 44.77% and 3 year total shareholder return of 142.71% suggest momentum has been...

Earlier this week, Discovery Silver reported first-quarter 2026 gold production of 60,269 ounces at its Porcupine operations and released extensive drill results across Hoyle Pond, TVZ, Owl Creek, Pamour and Dome, while also confirming work toward updated mineral resources later in 2026. The combination of solid production and drilling that aligns closely with, or improves on, existing resource models suggests Porcupine’s long-term mine plan and resource definition work are progressing in...

Why DigitalOcean’s recent earnings are drawing fresh attention DigitalOcean Holdings (DOCN) is back on investor radar after reporting Q4 2025 results ahead of expectations, with 18% year-over-year revenue growth and higher non-GAAP EPS supported by rising AI client recurring revenue. See our latest analysis for DigitalOcean Holdings. The share price has rallied strongly over the past year, with a 90 day share price return of 77.6% and a 1 year total shareholder return of 209.63%. This...

PennyMac Financial Services and PennyMac Mortgage Investment Trust recently launched the “Welcome Home: Athlete Mortgage Program,” extending specialized mortgage guidance, exclusive benefits, and educational resources to the wider Team USA athlete community in partnership with the U.S. Olympic & Paralympic Committee. The initiative highlights Pennymac’s effort to cultivate a differentiated client base by tailoring lending support to the unique financial profiles of elite athletes. Next,...

Shoals Technologies Group recently reported quarterly results showing revenue growing 38.6% year on year, ahead of expectations, but paired this with softer full-year EBITDA guidance that pointed to pressure on profitability as the business expands. Management also highlighted growing exposure to battery energy storage systems and solar projects deferred into 2025, which are reshaping the company’s near-term mix of opportunities and risks. An important nuance is that while robust revenue...

Earlier in April 2026, SharkNinja, Inc. broadened its premium lineup by launching new Ninja Luxe Café machines, including a limited-edition David Beckham collaboration, and introducing the Shark PowerDetect Speed Clean & Empty cordless vacuum with advanced detection features and an Auto-Empty Dock priced at US$499. These launches highlight SharkNinja’s push deeper into premium at-home coffee and intelligent cleaning, blending high-end design, personalization, and convenience-focused...

There's been a notable change in appetite for Calix, Inc. ( NYSE:CALX ) shares in the week since its quarterly report...

Antero Midstream Corporation ( NYSE:AM ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

If you are wondering whether Alkane Resources at around A$1.60 is still offering value or has already priced in the story, you are asking the right question. The share price has had a mixed short term pattern, with an 11.6% decline over 7 days, an 8.8% gain over 30 days, and returns of 15.9% year to date and 113.3% over the past year. These moves sit against a backdrop of ongoing attention on rare earths and gold producers. Funding, project timelines, and permitting updates often influence...

Travere Therapeutics (TVTX) just secured full FDA approval for FILSPARI in focal segmental glomerulosclerosis without nephrotic syndrome, extending its use beyond IgA nephropathy and reshaping how investors may think about the company’s rare kidney portfolio. See our latest analysis for Travere Therapeutics. The FDA decision arrives alongside a sharp 46.95% 1 month share price return and a 37.57% 3 month share price return, while the 1 year total shareholder return of 120.95% points to strong...

Edgewise Therapeutics (EWTX) has drawn investor attention after recent trading left the stock around $31.58, with returns showing mixed short term moves but a strong year to date and 1 year profile. See our latest analysis for Edgewise Therapeutics. Recent trading has been choppy, with a 1 day share price return of 1.12% and a 7 day share price return of an 8.28% decline. However, momentum over the past 90 days and year to date remains positive, supported by a 1 year total shareholder return...

Atomera Incorporated recently announced it has expanded its long-running collaboration with Synopsys to develop gallium nitride (GaN) device modeling workflows for radio frequency and power semiconductor applications using Synopsys’ Sentaurus TCAD and Atomera’s MSTcad toolset. This move extends Atomera’s MST modeling capabilities into GaN, potentially deepening its role in high-value RF and power markets by integrating more tightly into Synopsys’ widely used design ecosystem. We’ll now...

Evolv Technologies Holdings, Inc. recently announced multi-year subscription agreements and marketing partnerships with the University of Washington’s athletic department and Crypto.com Arena, expanding deployments of its Evolv Express Gen2 and eXpedite AI-based screening systems across major college and professional sports venues. These high-traffic stadium and arena wins highlight growing adoption of Evolv’s subscription-based security platforms in sports and entertainment, reinforcing its...

The American Academy of Dermatology’s new pediatric guidelines give a strong, evidence-backed endorsement to Arcutis Biotherapeutics (ARQT) lead product ZORYVE for children with mild to moderate atopic dermatitis, highlighting efficacy, safety, and long-term use. See our latest analysis for Arcutis Biotherapeutics. At a share price of $23.26, Arcutis has a 1 day share price return of 1.75%, while the year to date share price return of 19.79% decline contrasts with a 1 year total shareholder...

Recent returns and business snapshot Asahi Group Holdings (TSE:2502) has recently drawn attention after a stretch of mixed share returns, including a 0.6% decline in the latest session and weaker performance over the past year. The company operates a broad beverage and food portfolio across Japan, Europe, Oceania, and Southeast Asia, generating revenue of ¥2,926,294 and net income of ¥155,563, with annual revenue growth of 3.9% and net income growth of 10.3%. See our latest analysis for Asahi...

Recent performance and context for W.W. Grainger W.W. Grainger (GWW) has drawn fresh investor attention after recent share price moves, with the stock showing mixed short term returns but positive performance over the month and the past 3 months. See our latest analysis for W.W. Grainger. Recent trading has been slightly softer, with a 1-day share price return of 1.45% and a 7-day share price return of 1.29%. That sits against a 30-day share price return of 6.7% and a 1-year total shareholder...